Mlt (200 microM) affect selectively the processes of lymphoblastoid cell growth.

Involvement of melatonin-induced-immuno-opioids in the development of the lymphomas. Melatonin 4 mg/kg bw, chronically treated.

Di Bella multitherapy did not show sufficient efficacy in patients with advanced cancer to warrant further clinical testing.

Melatonin could be a potential chemotherapeutic/preventive agent for malignant lymphocytes, where melatonin-induced apoptosis, melatonin can induce caspase activation independent from these receptors.

Kinetics of changes of enterochromaffin cells appears to be related with definite antiblastic properties inherent to melatonin and serotonin.

No abstract.

No abstract.

Patients with multiple myeloma showed significantly higher mean melatonin serum levels, increased secretion might be considered as a compensatory mechanism of regulating neoplastic growth.

The roles of the indole nucleus and the side chain in the determination of the antigenic properties of the molecule are discussed.

Anti-melatonin monoclonal antibodies (Mab) may be useful for immunoassay of melatonin.